Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
PEY.TO 0.26CP.TO -0.12BRK.B -0.78MSFT -6.85META 5.46BKNG 1.645HMP.TO -0.01SPGP 0.13
Valeant Pharmaceuticals (VRX.TO)
The ultimate 360° Tracker Your financial life in one place, automatically

Valeant Pharmaceuticals (VRX.TO)

0.00
-0.00 (0.00%)
39 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
BUY

Valeant Pharmaceuticals(VRX.TO)

Jan 20, 2003
Volatile. Good for short and long term. Expect earnings will go up.
Photo of Pierre BernardPierre BernardUnlock Rating
$46.76

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Jan 14, 2003
A trading stock. Could be a buy for the long term.
Photo of Michael SmedleyMichael SmedleyUnlock Rating
$46.20

Stock price when the opinion was issued

Healthcare
TOP PICK

Valeant Pharmaceuticals(VRX.TO)

Jan 10, 2003
(Was a top pick Oct 30. Down %) Great generic drugs. Good contracts.Trading at 10 X earnings.
Photo of Gordon Higgins, CA, MBAGordon Higgins, CA, MBAUnlock Rating
$44.95

Stock price when the opinion was issued

Healthcare
TOP PICK

Valeant Pharmaceuticals(VRX.TO)

Jan 09, 2003
Buy at $39/39.50.
Photo of Brian Acker, CABrian Acker, CAUnlock Rating
$44.64

Stock price when the opinion was issued

Healthcare
HOLD

Valeant Pharmaceuticals(VRX.TO)

Jan 02, 2003
Good range of products. Positive company.
Photo of Michael SmedleyMichael SmedleyUnlock Rating
$43.59

Stock price when the opinion was issued

Healthcare
WEAK BUY

Valeant Pharmaceuticals(VRX.TO)

Jan 02, 2003
Management has not always been forthcoming. New drugs are coming out.Large cash flow. Good valuation.
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$10.75

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Dec 27, 2002
Generic drug sector shows good promise. There were rumours of inside trading. At a good price.
Photo of Jeff MorrisonJeff MorrisonUnlock Rating
$40.20

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Dec 27, 2002
Buy for a January rally.
Photo of Brian Acker, CABrian Acker, CAUnlock Rating
$40.20

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

Dec 19, 2002
Controversy seems to swim around this company. New product may not sell as well as hoped.
Photo of Laura WallaceLaura WallaceUnlock Rating
$39.18

Stock price when the opinion was issued

Healthcare
WEAK BUY

Valeant Pharmaceuticals(VRX.TO)

Dec 18, 2002
Insider selling is a problem. Nice products. Good price.
Photo of Robert FloydRobert FloydUnlock Rating
$39.80

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Dec 18, 2002
At a good valuation now. A high quality company.
Photo of John Sinkins, CFAJohn Sinkins, CFAUnlock Rating
$39.80

Stock price when the opinion was issued

Healthcare
WEAK BUY

Valeant Pharmaceuticals(VRX.TO)

Dec 17, 2002
Volatile. Will always be involved in patent litigation and FDA approvals.
Photo of David BaskinDavid BaskinUnlock Rating
$43.15

Stock price when the opinion was issued

Healthcare
PAST TOP PICK

Valeant Pharmaceuticals(VRX.TO)

Dec 16, 2002
(Was a top pick on Oct 28. Down 49.5%) Still likes.
Photo of David BurrowsDavid BurrowsUnlock Rating
$45.85

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

Dec 12, 2002
Below fair market value. Not fully trusting of management at this time.
Photo of Ross HealyRoss HealyUnlock Rating
$46.70

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Dec 11, 2002
Reasonably cheap. Should have some upside.
Photo of Bruce Campbell (1)Bruce Campbell (1)Unlock Rating
$50.25

Stock price when the opinion was issued

Healthcare
Showing 571 to 585 of 714 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

CCO.TO 1.26$151.04
TOU.TO -0.47$60.79
BTE.TO -0.22$5.91
ADM -1.245$78.025
ATRL.TO 0.06$83.97

Today's Top Picks

PEY.TO 0.26$24.91
CP.TO -0.12$124.8
BRK.B -0.78$494.74
MSFT -6.85$392.91
META 5.46$598.94

Popular Articles

Latest Sell Signals

OTEX.TO 0.14$30.96
BSX 0.165$46.925
GIL.TO -16.24$70.39
SHOP.TO 1.22$158.49
WCN.TO 3.21$219.59

Most Recent Experts

Keith Richards

Keith Richards

ValueTrend Wealth Management

Joe Terranova

Joe Terranova

Virtus Investment Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Rob Sechan, Managing Partner, New Edge Capital

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

Gordon Reid

Gordon Reid

GoodReid Investment Counsel

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica